Keegan Paradis grew up watching his father, Brendon, lose his vision to a condition no one could name. "My wife said, 'Take ...

We asked ophthalmologists what stands out to them in the history of treating glaucoma and where future treatments might be heading.

(HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a ...

Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

Optic neuropathy and recurrence of papilledema in patients with craniosynostosis may be a clinically useful biomarker by PHOMS.